Skip to Content

B853 (Repaglinide 0.5 mg)

Pill with imprint B853 is White, Round and has been identified as Repaglinide 0.5 mg. It is supplied by Breckenridge Pharmaceutical, Inc..

Repaglinide is used in the treatment of diabetes, type 2 and belongs to the drug class meglitinides. Risk cannot be ruled out during pregnancy. Repaglinide 0.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for B853

Repaglinide 0.5 mg B853

Repaglinide

Imprint
B853
Strength
0.5 mg
Color
White
Shape
Round
Availability
Prescription only
Drug Class
Meglitinides
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Breckenridge Pharmaceutical, Inc.
National Drug Code (NDC)
51991-0853

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.